Select a metric from the list below to chart it
Metric | Sep '19 | Sep '20 | Sep '21 | Jun '22 | Jun '23 | LTM |
---|---|---|---|---|---|---|
Total Revenues | 194.2 | 130.5 | 300.6 | 482.3 | 1,044.2 | 1,042.7 |
Total Revenues % Chg. | — | -32.8% | 130.4% | 60.4% | 116.5% | 58.9% |
Cost of Goods Sold, Total | 85.7 | 50.9 | 163.0 | 199.9 | 373.6 | 380.5 |
Gross Profit | 108.5 | 79.6 | 137.6 | 282.4 | 670.6 | 662.1 |
Selling General & Admin Expenses, Total | 69.9 | 54.6 | 135.9 | 180.0 | 644.3 | 641.0 |
R&D Expenses | 41.6 | 36.8 | 59.6 | 79.8 | 209.3 | 213.3 |
Other Operating Expenses, Total | 111.5 | 91.4 | 195.6 | 259.8 | 853.7 | 854.3 |
Operating Income | -3.0 | -11.8 | -58.0 | 22.6 | -183.1 | -192.1 |
Interest Expense, Total | -0.2 | -0.1 | -0.1 | -0.3 | — | — |
Interest And Investment Income | — | — | — | 3.5 | 31.9 | 40.9 |
Net Interest Expenses | -0.2 | -0.1 | -0.1 | 3.2 | 31.9 | 40.9 |
Currency Exchange Gains (Loss) | 3.0 | -4.9 | -5.5 | -1.2 | -4.1 | 48.7 |
Other Non Operating Income (Expenses) | 1.0 | 0.6 | 0.1 | 0.2 | -25.3 | -25.3 |
EBT, Excl. Unusual Items | 0.7 | -16.2 | -63.4 | 24.8 | -180.6 | -127.8 |
Restructuring Charges | -2.1 | -6.2 | -2.5 | -0.3 | — | 0.0 |
EBT, Incl. Unusual Items | -1.4 | -22.4 | -65.9 | 24.4 | -180.6 | -127.8 |
Income Tax Expense | -7.0 | -2.1 | -45.3 | -17.5 | -72.8 | 3.3 |
Earnings From Continuing Operations | 5.6 | -20.3 | -20.6 | 41.9 | -107.8 | -131.0 |
Net Income | 5.6 | -20.3 | -20.6 | 41.9 | -107.8 | -131.0 |
Net Income to Common Incl Extra Items | 5.6 | -20.3 | -20.6 | 41.9 | -107.8 | -131.0 |
Net Income to Common Excl. Extra Items | 5.6 | -20.3 | -20.6 | 41.9 | -107.8 | -131.0 |
Total Shares Outstanding | — | 36.3 | 36.3 | 64.4 | 64.5 | 63.9 |
Weighted Avg. Shares Outstanding | — | 36.3 | 36.3 | 39.8 | 64.6 | 64.6 |
Weighted Avg. Shares Outstanding Dil | — | 36.3 | 36.3 | 39.8 | 64.6 | 64.6 |
EPS | — | -0.6 | -0.6 | 1.1 | -1.7 | -2.0 |
EPS Diluted | — | -0.6 | -0.6 | 1.1 | -1.7 | -2.0 |
EBITDA | 11.6 | 16.8 | 67.7 | 172.9 | 308.4 | 300.0 |